Login to continue
This content is intended for healthcare professionals in the UK only.
In order to provide you with the best possible experience you will need to consent to have contact from Ferring.
If you have done this, simply enter your email address and click the verification button.
A OneTimePasscode will be sent to your inbox.
If you have not already consented please click on "Create an account" and complete the form to gain instant access.
You can unsubscribe at any time
Create Account
Enter code to login
(sent to )
Please contact a Ferring Representative in order to get an account for accessing the secured area
You are leaving the Ferring MedicalCONNECT website, please check the privacy policy and content within these links is appropriate for you. We cannot be held accountable for the validity of information on any 3rd party websites not owned and managed by Ferring UK
Continue Go BackPlease select an option
Please select your primary Therapeutic Area
All content within this section is available for the education and development of healthcare professionals who are seeking support and guidance in therapy & treatment of diseases.
If you wish to understand more about Ferring's products and are an HCP, please visit Ferring HCP Hub
If you are a member of public, please visit Ferring UK to get more information.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Ferring Pharmaceuticals Ltd by clicking the ‘Adverse Events’ link above. Tel:0800 111 4126 or by email medical.uk@ferring.com
© 2024 Ferring. Ferring and the Ferring Pharmaceuticals logo and, unless otherwise specified, all product names and service names are trademarks owned by, or licensed to, the Ferring group of companies. All other trademarks are the property of their respective owner(s). UK-nonP-2400006 Date of Preparation April 2024
UK-nonP-2400006 Date of Preparation April 2024
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Ferring Pharmaceuticals Ltd by clicking the ‘Adverse Events’ link above. Tel:0800 111 4126 or by email medical.uk@ferring.com
© 2024 Ferring. Ferring and the Ferring Pharmaceuticals logo and, unless otherwise specified, all product names and service names are trademarks owned by, or licensed to, the Ferring group of companies. All other trademarks are the property of their respective owner(s).
Description of the audio goes here. You can provide additional details or information about the audio.